Artificial Intelligence in Drug Discovery

May 14, 2018

PODCASTERS 

“Get knowledge and inspiration to apply artificial intelligence to drug development. Discover startups applying machine learning to biomedical research. Hear how biotech and pharma companies use AI to speed discovery and cut costs. Learn from academic researchers pushing boundaries in applying computation to biology. We interview leaders transforming drug development with data and algorithms. Subscribe now and never miss an episode!”

 

A podcast on Spotify for Podcasters: The podcasts explores the transformative role of artificial intelligence (AI) in drug discovery, particularly emphasizing the efforts of the company FDNA. FDNA leverages AI to accelerate the identification and development of new pharmaceuticals, aiming to make the drug discovery process faster, more cost-effective, and more efficient. The podcast delves into various AI technologies and methodologies that can pinpoint potential drug candidates, predict their efficacy, and identify possible side effects, ultimately revolutionizing the traditional paradigms in pharmaceutical research and development.

 

Related articles

AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading
Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading